Merck Serono Aims To Expand Sales In Japan
This article was originally published in PharmAsia News
Executive SummaryMerck Serono Japan's new president Mark Smith disclosed that the company expects to expand sales in Japan to account for 7 percent of its global sales by 2015
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.